A multimethods randomized trial found that plain language versions improved parents' understanding of health recommendations.
COVID-19
Child health
Guideline
Health recommendations
Knowledge mobilization
Parents
Plain language
Journal
Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
13
01
2023
revised:
02
06
2023
accepted:
23
06
2023
medline:
3
11
2023
pubmed:
9
7
2023
entrez:
8
7
2023
Statut:
ppublish
Résumé
To assess the effectiveness of plain language compared with standard language versions of COVID-19 recommendations specific to child health. Pragmatic, allocation-concealed, blinded, superiority randomized controlled trial with nested qualitative component. Trial was conducted online, internationally. Parents or legal guardians (≥18 years) of a child (<18 years) were eligible. Participants were randomized to receive a plain language recommendation (PLR) or standard (SLV) verison of a COVID-19 recommendation specific to child health. Primary outcome was understanding. Secondary outcomes included: preference, accessibility, usability, satisfaction, and intended behavior. Interviews explored perceptions and preferences for each format. Between July and August 2022, 295 parents were randomized; 241 (81.7%) completed the study (intervention n = 121, control n = 120). Mean understanding scores were significantly different between groups (PLR 3.96 [standard deviation (SD) 2.02], SLV 3.33 [SD 1.88], P = 0.014). Overall participants preferred the PLR version: mean rating 5.05/7.00 (95% CI 4.81, 5.29). Interviews (n = 12 parents) highlighted their preference for the PLR and provided insight on elements to enhance future knowledge mobilization of health recommendations. Compared to SLVs, parents preferred PLRs and better understood the recommendation. Guideline developers should strive to use plain language to increase understanding, uptake, and implementation of evidence by the public.
Identifiants
pubmed: 37421995
pii: S0895-4356(23)00165-8
doi: 10.1016/j.jclinepi.2023.06.018
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT05358990']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8-19Subventions
Organisme : CIHR
ID : GA3-177732
Pays : Canada
Organisme : CIHR
ID : FRN VR4-172741
Pays : Canada
Organisme : CIHR
ID : REC 183,153
Pays : Canada
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no conflicts of interest to declare.